Display options
Share it on

Iran J Pharm Res. 2015;14(4):1263-8.

Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety).

Iranian journal of pharmaceutical research : IJPR

Javad Kiani, Saman Ahmad Nasrollahi, Farzaneh Esna-Ashari, Puyan Fallah, Firuzeh Sajedi

Affiliations

  1. Division of Endocrinology, Department of Internal Medicine, School of Medicine, Hamedan University of Medical Sciences, Hamedan, Iran.
  2. Center for Research and Training in Skin Diseases and Leprosy (CRTSDL), Tehran University of Medical Sciences, Tehran, Iran.
  3. Department of Community Medicine, School of Medicine, Hamedan University of Medical Sciences, Hamedan, Iran.
  4. Department of Internal Medicine, School of Medicine, Hamedan University of Medical Sciences, Hamedan, Iran.

PMID: 26664395 PMCID: PMC4673956

Abstract

Because of less systemic side effects of topical medications in pain relief of the painful form of diabetic peripheral neuropathy, this study aimed to compare the effect of amitriptyline and capsaicin cream in relieving pain in this condition. In this randomized, double-blind and non -inferiority trial, 102 patients received amitriptyline 2% and capsaicin 0.75% creams 3 times a day for 12 weeks on the feet. Pain relief was measured by the visual analog scale (0-10). Treatment responding was considered as cure rate greater than 50% from baseline. Evaluations of the pain severity, compliance and drugs adverse effects were performed at each of the 4-week follow -up visits. Both drugs significantly relieved pain in 12 weeks compared with baseline values (P < 0.001 for both). Treatment responders were similar in both groups (P = 0.545). Intention-To-Treat analysis showed no significant difference in the efficacy between the two treatments (P = 0.703). Adverse events were more common in capsaicin group (P = 0.001). Dermatologic complications were the most common: itching, blister formation and erythema in the capsaicin group and skin dryness and itching in the amitriptyline group. This study demonstrates the similar efficacy of amitriptyline cream with capsaicin cream in managing diabetic neuropathic pain with fewer side effects.

Keywords: Capsaicin; amitriptyline; cream; diabetic neuropathy; pain

References

  1. Clin J Pain. 2000 Jun;16(2 Suppl):S49-55 - PubMed
  2. Reg Anesth Pain Med. 2003 Jul-Aug;28(4):289-93 - PubMed
  3. Anesthesiology. 2005 Jul;103(1):140-6 - PubMed
  4. J Pain Symptom Manage. 1994 Oct;9(7):425-33 - PubMed
  5. Drugs Aging. 1995 Oct;7(4):317-28 - PubMed
  6. Clin J Pain. 2003 Sep-Oct;19(5):323-8 - PubMed
  7. Pain. 2004 Aug;110(3):697-706 - PubMed
  8. Neurology. 1995 Jun;45(6):1115-21 - PubMed
  9. Pain Pract. 2012 Feb;12(2):148-53 - PubMed
  10. Clin J Pain. 2008 Jan;24(1):51-5 - PubMed
  11. J Pain Res. 2010 Dec 20;4:11-24 - PubMed
  12. Diabetes Care. 2008 Feb;31 Suppl 2:S255-61 - PubMed
  13. Drugs Aging. 1996 Jun;8(6):459-76 - PubMed
  14. Diabetologia. 1993 Feb;36(2):150-4 - PubMed
  15. Br J Anaesth. 2011 Oct;107(4):490-502 - PubMed
  16. J Pain. 2005 Oct;6(10):644-9 - PubMed
  17. Endocrinol Nutr. 2010 Nov;57(9):414-20 - PubMed
  18. Support Care Cancer. 2012 Jul;20(7):1515-24 - PubMed
  19. Neurology. 1998 Oct;51(4):1166-71 - PubMed
  20. Pain Pract. 2013 Jul;13(6):497-503 - PubMed

Publication Types